Article
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
13 Nov 2020
Abstract excerpt
Most patients with biliary tract cancer (BTC) are diagnosed with advanced disease, relapse rates are high in those undergoing surgery and prognosis remains poor, while the incidence is increasing. Treatment options are limited, and chemotherapy is still the standard of care in both adjuvant and advanced disease setting. In recent years, different subtypes of BTC have been defined depending on the anatomical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
